{"id":"https://openalex.org/W2272200366","doi":"https://doi.org/10.1111/1346-8138.13258","title":"Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double\u2010blind, phase 3 study","display_name":"Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double\u2010blind, phase 3 study","publication_year":2016,"publication_date":"2016-02-15","ids":{"openalex":"https://openalex.org/W2272200366","doi":"https://doi.org/10.1111/1346-8138.13258","mag":"2272200366","pmid":"https://pubmed.ncbi.nlm.nih.gov/26875540","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5067558"},"language":"en","primary_location":{"id":"doi:10.1111/1346-8138.13258","doi":"https://doi.org/10.1111/1346-8138.13258","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.13258","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13258","source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13258","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015950702","display_name":"Akihiko Asahina","orcid":"https://orcid.org/0000-0001-6127-3182","observed_orcids":["https://orcid.org/0000-0001-6127-3182"]},"institutions":[{"id":"https://openalex.org/I115498069","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22","country_code":"JP","type":"education","lineage":["https://openalex.org/I115498069"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Akihiko Asahina","raw_affiliation_strings":["Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I115498069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046156143","display_name":"Takafumi Etoh","orcid":"https://orcid.org/0009-0004-0495-9064","observed_orcids":["https://orcid.org/0009-0004-0495-9064"]},"institutions":[{"id":"https://openalex.org/I4210141191","display_name":"Tokyo Teishin Hospital","ror":"https://ror.org/04j339g17","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210141191"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takafumi Etoh","raw_affiliation_strings":["Department of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210141191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033463436","display_name":"Atsuyuki Igarashi","orcid":"https://orcid.org/0000-0002-5903-3187","observed_orcids":["https://orcid.org/0000-0002-5903-3187"]},"institutions":[{"id":"https://openalex.org/I2801547476","display_name":"NTT Medical Center","ror":"https://ror.org/0285prp25","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2801547476"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuyuki Igarashi","raw_affiliation_strings":["Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I2801547476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080374235","display_name":"Shinichi Imafuku","orcid":"https://orcid.org/0000-0001-8568-4349","observed_orcids":["https://orcid.org/0000-0001-8568-4349"]},"institutions":[{"id":"https://openalex.org/I31784960","display_name":"Fukuoka University","ror":"https://ror.org/04nt8b154","country_code":"JP","type":"education","lineage":["https://openalex.org/I31784960"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichi Imafuku","raw_affiliation_strings":["Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan","institution_ids":["https://openalex.org/I31784960"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024531277","display_name":"Hidehisa Saeki","orcid":"https://orcid.org/0000-0002-1095-0355","observed_orcids":["https://orcid.org/0000-0002-1095-0355"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidehisa Saeki","raw_affiliation_strings":["Department of Dermatology, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045867835","display_name":"Yoshiyuki Shibasaki","orcid":"https://orcid.org/0009-0003-0434-541X","observed_orcids":["https://orcid.org/0009-0003-0434-541X"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Shibasaki","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062440318","display_name":"Yukiko Tomochika","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukiko Tomochika","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047478496","display_name":"Shigeyuki Toyoizumi","orcid":"https://orcid.org/0000-0002-7011-5263","observed_orcids":["https://orcid.org/0000-0002-7011-5263"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeyuki Toyoizumi","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Makoto Nagaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Nagaoka","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067909005","display_name":"Mamitaro Ohtsuki","orcid":"https://orcid.org/0000-0001-7845-6698","observed_orcids":["https://orcid.org/0000-0001-7845-6698"]},"institutions":[{"id":"https://openalex.org/I146500386","display_name":"Jichi Medical University","ror":"https://ror.org/010hz0g26","country_code":"JP","type":"education","lineage":["https://openalex.org/I146500386"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mamitaro Ohtsuki","raw_affiliation_strings":["Department of Dermatology, Jichi Medical University, Tochigi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Jichi Medical University, Tochigi, Japan","institution_ids":["https://openalex.org/I146500386"]}]},{"author_position":"last","author":{"id":null,"display_name":"the study investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the study investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5015950702"],"corresponding_institution_ids":["https://openalex.org/I115498069"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":5.5902,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.96846076,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"43","issue":"8","first_page":"869","last_page":"880"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":1.0},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":1.0},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7540000081062317},{"id":"https://openalex.org/keywords/pasi-75","display_name":"PASI 75","score":0.8740000128746033},{"id":"https://openalex.org/keywords/acr20","display_name":"ACR20","score":0.8970000147819519},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6150000095367432},{"id":"https://openalex.org/keywords/herpes-zoster","display_name":"herpes zoster","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9032402634620667},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.8682270050048828},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8507698774337769},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.8406744003295898},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6563410758972168},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6397936344146729},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6265984773635864},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.6051084995269775},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.6044420003890991},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4836355447769165},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4621048867702484},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4608663022518158},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4326429069042206},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.343961238861084},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.20015552639961243}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006562","descriptor_name":"Herpes Zoster","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/1346-8138.13258","doi":"https://doi.org/10.1111/1346-8138.13258","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.13258","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13258","source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:26875540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26875540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of dermatology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:5067558","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5067558/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Dermatol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/1346-8138.13258","doi":"https://doi.org/10.1111/1346-8138.13258","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.13258","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13258","source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2272200366.pdf","grobid_xml":"https://content.openalex.org/works/W2272200366.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1503195240","https://openalex.org/W1541270304","https://openalex.org/W1546465212","https://openalex.org/W1607447489","https://openalex.org/W1853421408","https://openalex.org/W1892175722","https://openalex.org/W1964306038","https://openalex.org/W1965032245","https://openalex.org/W1973354423","https://openalex.org/W1974321634","https://openalex.org/W1981700374","https://openalex.org/W1982615083","https://openalex.org/W2001100153","https://openalex.org/W2005176759","https://openalex.org/W2008716526","https://openalex.org/W2016325865","https://openalex.org/W2016898503","https://openalex.org/W2021018799","https://openalex.org/W2027145044","https://openalex.org/W2028648418","https://openalex.org/W2031157372","https://openalex.org/W2034728532","https://openalex.org/W2036344824","https://openalex.org/W2045317929","https://openalex.org/W2058562555","https://openalex.org/W2064709295","https://openalex.org/W2080165152","https://openalex.org/W2083180635","https://openalex.org/W2092066512","https://openalex.org/W2096991001","https://openalex.org/W2103120331","https://openalex.org/W2107510226","https://openalex.org/W2116956799","https://openalex.org/W2120422600","https://openalex.org/W2126057417","https://openalex.org/W2133696182","https://openalex.org/W2137101132","https://openalex.org/W2138647255","https://openalex.org/W2149168537","https://openalex.org/W2156148414","https://openalex.org/W2160630176","https://openalex.org/W2163184895","https://openalex.org/W2163232748","https://openalex.org/W2166077573","https://openalex.org/W2167305078","https://openalex.org/W2172257129","https://openalex.org/W2281407591","https://openalex.org/W2317900027","https://openalex.org/W2324161037","https://openalex.org/W2734390848","https://openalex.org/W3086306921","https://openalex.org/W4233561050","https://openalex.org/W4248269869"],"related_works":["https://openalex.org/W2735558737","https://openalex.org/W1892175722","https://openalex.org/W2616575727","https://openalex.org/W2167305078","https://openalex.org/W2283622962","https://openalex.org/W3020131431","https://openalex.org/W4390790402","https://openalex.org/W7217280621","https://openalex.org/W2891620699","https://openalex.org/W2804131537"],"abstract_inverted_index":{"Tofacitinib":[0,239],"is":[1,8],"an":[2],"oral":[3],"Janus":[4],"kinase":[5],"inhibitor":[6],"that":[7],"being":[9],"investigated":[10],"for":[11,43,50,97,111,125,147],"psoriasis":[12,28,130,251],"and":[13,82,86,99,175,184,190,224],"psoriatic":[14,30,114,148,198,253],"arthritis.":[15,115],"Japanese":[16],"patients":[17,72,112,121,178,196,214,245],"aged":[18],"20":[19],"years":[20],"or":[21,39,56,92,101,236],"more":[22,102],"with":[23,113,181,197,246,263],"moderate":[24,126,247],"to":[25,36,60,127,248],"severe":[26,128,249],"plaque":[27,129,250],"and/or":[29,252],"arthritis":[31,149,199,254],"were":[32,68,203,260],"double-blindly":[33],"randomized":[34],"1:1":[35],"tofacitinib":[37,182],"5":[38,55,183],"10":[40,47,57,137,156,185],"mg":[41,48,58,132,138,151,157,169,186],"b.i.d.":[42,49,59],"16":[44,67],"weeks,":[45,52],"open-label":[46],"4":[51],"then":[53],"variable":[54],"Week":[61,66,172,206,216],"52.":[62,207],"Primary":[63],"end-points":[64],"at":[65,74],"the":[69],"proportion":[70],"of":[71,90,107,177,213],"achieving":[73],"least":[75],"a":[76],"75%":[77],"reduction":[78],"in":[79,104,211,244],"Psoriasis":[80],"Area":[81],"Severity":[83],"Index":[84],"(PASI75)":[85],"Physician's":[87],"Global":[88],"Assessment":[89],"\"clear\"":[91],"\"almost":[93],"clear\"":[94],"(PGA":[95],"response)":[96],"psoriasis,":[98],"20%":[100],"improvement":[103],"American":[105],"College":[106],"Rheumatology":[108],"criteria":[109,124,146,167],"(ACR20)":[110],"Safety":[116],"was":[117],"assessed":[118],"throughout.":[119],"Eighty-seven":[120],"met":[122,144,165],"eligibility":[123,145],"(5":[131,150],"b.i.d.,":[133,139,152,158,187],"n":[134,140,153,159],"=":[135,141,154,160],"43;":[136],"44),":[142],"12":[143],"4;":[155],"8)":[161],"including":[162,218],"five":[163],"who":[164],"both":[166],"(10":[168],"b.i.d.).":[170],"At":[171],"16,":[173],"62.8%":[174],"72.7%":[176],"achieved":[179,192,200],"PASI75":[180],"respectively;":[188],"67.4%":[189],"68.2%":[191],"PGA":[193],"responses;":[194],"all":[195],"ACR20.":[201],"Responses":[202],"maintained":[204],"through":[205,215,255],"Adverse":[208],"events":[209,223,235],"occurred":[210],"83%":[212],"52,":[217],"four":[219],"(4.3%)":[220],"serious":[221,227],"adverse":[222],"three":[225],"(3.2%)":[226],"infections":[228],"(all":[229],"herpes":[230],"zoster).":[231],"No":[232],"malignancies,":[233],"cardiovascular":[234],"deaths":[237],"occurred.":[238],"(both":[240],"doses)":[241],"demonstrated":[242],"efficacy":[243],"52":[256],"weeks;":[257],"safety":[258],"findings":[259],"generally":[261],"consistent":[262],"prior":[264],"studies.":[265]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}